As fashionable medicine Ozempic and Mounjaro have change into a part of the favored panorama, so have compound weight reduction medicines. Whereas many people have face obstacles getting their medicines authorized by insurance coverage, an alternative choice has come available. Compounded weight reduction medicines are specifically formulated and supply an alternate for these searching for efficient weight reduction options when their prescription choices are restricted. Questions come up about their security, effectiveness and composition in comparison with pharmaceutical model names, so we tapped the specialists to get a deal with on this rising pattern.
Insurance coverage Protection Challenges
Insurance coverage points have performed a big function in driving people to discover compounded weight reduction medicines as a substitute for pharmaceutical model names like semaglutide and tirzepatide. New York endocrinologist Caroline Messer, MD highlights a number of insurance-related challenges which have prompted this shift. “Semaglutide has two FDA-approved variations: Ozempic and Wegovy. Ozempic is just authorized for adults with kind 2 diabetes, and Wegovy is just authorized for weight administration. The overwhelming majority of sufferers with diabetes can acquire insurance coverage protection for Ozempic, however sadly, sufferers with borderline diabetes (prediabetes/insulin resistance) are excluded from protection.”